Protein Engineering Market Size

Protein Engineering Market Size

Protein Engineering Market size was valued at over USD 2.5 billion in 2023 and is estimated to grow at 15.9% CAGR from 2024 to 2032 due to the growing collaborations and partnerships for fostering innovations and advancements in the field.

To get key market trends

  Download Free Sample

Researchers and biotech firms are pooling resources and expertise to develop novel techniques for protein modification and designs. This ongoing synergy among industry stakeholders is promising to transform drug discovery and biotechnology leading to the creation of new therapeutics and diagnostics with improved efficacy and specificity for benefiting patients worldwide. For instance, in March 2024, BRAIN Biotech and AMSilk collaborated on protein engineering for enhancing structural proteins for performance materials. This partnership marked the first patent application, showcasing BRAIN Biotech's reliance on protein engineering and bioinformatics for rational protein design.
 

The rising frequency of protein-deficient disorders, such as marasmus and kwashiorkor especially in developing and underdeveloped countries, is also increasing the demand for protein engineering. Scientists are continually developing novel protein-based therapies to combat these conditions while focusing to provide effective treatment options for the affected population.
 

Furthermore, protein engineering will play an increasingly pivotal role in addressing protein-deficient disorders by creating enhanced therapeutic proteins with improved efficacy and accessibility. The ongoing research for focusing on developing cost-effective solutions to ensure that these vital treatments reach those in need across the globe will also favor the industry development. For instance, in May 2023, UNICEF highlighted that nearly half of the deaths in children under 5 years of age stem from undernutrition. This is underscoring the critical role of protein engineering in developing nutritional interventions to combat undernutrition for potentially reducing mortality rates and enhancing child health globally.
 

However, the high development costs and limited clinical validation may hinder the market progress to some extent. Researchers are seeking innovative funding models and conducting ongoing trials to address these challenges. In addition, collaborations between academia, industry, and regulatory bodies will play a vital role in reducing costs and enhancing validation processes, ultimately facilitating the translation of protein engineering research into clinical applications.